[1]孙卫格张冉袁媛杨燕琳郅浩亮张慧鑫蔡卫新.神经外科患者深静脉血栓发生率的Meta分析[J].中国卫生质量管理,2023,30(02):29-35.[doi:10.13912/j.cnki.chqm.2023.30.2.08 ]
　SUN Weige,ZHANG Ran,YUAN Yuan.The Incidence of Deep Vein Thrombosis in Neurosurgery Patients: A Meta-Analysis[J].Chinese Health Quality Management,2023,30(02):29-35.[doi:10.13912/j.cnki.chqm.2023.30.2.08 ]

点击复制

神经外科患者深静脉血栓发生率的Meta分析

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R] 卷: 第30卷期数: 2023年02期页码: 29-35 栏目: 医疗质量出版日期: 2023-02-15

Title:: The Incidence of Deep Vein Thrombosis in Neurosurgery Patients: A Meta-Analysis

作者:: 孙卫格张冉袁媛杨燕琳郅浩亮张慧鑫蔡卫新; 首都医科大学附属北京天坛医院

Author(s):: SUN Weige; ZHANG Ran; YUAN Yuan; Beijing Tiantan Hospital

关键词:: 神经外科; 深静脉血栓; 发生率; Meta分析; 护理管理

Keywords:: Neurosurgery; Deep Vein Thrombosis; Incidence; Meta-Analysis; Nursing Management

分类号:: R651;R543.6;R47

DOI:: 10.13912/j.cnki.chqm.2023.30.2.08

文献标志码:: A

摘要:: 目的通过Meta分析了解神经外科患者深静脉血栓（DVT）发生率。方法检索PubMed、Science Direct、 CINAHL、Web of Science、EMBASE、Cochrane Library、万方、维普、中国知网和中国生物医学文献数据库建库至2021年11月神经外科患者DVT发生率非实验性研究。由两名研究者独立筛选文献、提取资料、评价文献质量。采用RevMan 5.3软件进行Meta分析。结果共纳入43篇文献，样本量为258 873例。Meta分析结果显示，神经外科患者DVT发生率为16%［95%CI（0.15,0.17）］。亚组分析结果显示，国内、神经外科重症监护病房、脑出血、资料来源于2017年-2021年的神经外科患者DVT发生率较高。结论神经外科患者DVT发生率较高。应从DVT预防和管理指南本土化、DVT早期预警及干预机制建立等方面入手，提高神经外科患者DVT评估和诊疗质量。

Abstract:: ObjectiveTo investigate the incidence of deep vein thrombosis (DVT) in neurosurgery patients through Meta-analysis.MethodsPubMed, Science Direct, CINAHL, Web of Science, EMBASE, Cochrane Library, Wanfang, VIP, CNKI and China Biomedical Literature Database were searched for non-experimental study on the incidence of DVT in neurosurgery patients from database creation to November 2021. Two researchers independently screened the literature, extracted the data and evaluated the quality of the literature. Meta-analysis was performed by RevMan 5.3 software. ResultsA total of 43 literatures were included, with a sample size of 258 873 cases. Meta-analysis showed that the incidence of DVT in neurosurgery patients was 16% ［95%CI (0.15,0.17)］. The results of subgroup analysis showed that the incidence of DVT was higher in domestic, neurosurgical intensive care units, cerebral hemorrhage, and neurosurgical patients with data from 2017 to 2021.Conclusion The incidence of DVT was higher in neurosurgical patients. The localization of DVT prevention and management guidelines, the establishment of DVT early warning and intervention mechanism and other aspects should be promoted to improve the evaluation and diagnosis and treatment quality of neurosurgery patients with DVT.

参考文献/References:

［1］GERALDINI F, DE CASSAI A, CORREALE C, et al. Predictors of deep-vein thrombosis in subarachnoid hemorrhage: a retrospective analysis［J］.Acta Neurochirurgica，2020, 162(9): 2295-2301. ［2］RETHINASAMY R,ALIAS A,KANDASAMY R,et al.Deep vein thrombosis and the neurosurgical patient［J］.Malays J Med Sci,2019, 26(5): 139-147. ［3］BUCHANAN IA,LIN M,DONOHO DA,et al.Predictors of venous thromboembolism after nonemergent craniotomy: a nationwide readmission database analysis［J］.World Neurosurgery,2020, 122: 1102-1110. ［4］KIMMELL KT, JAHROMI BS.Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy［J］. Journal of Neurosurgery,2014,122(5): 1004-1011. ［5］雷霆,刘方军，赵晓春，等.神经外科患者围手术期深静脉血栓形成的危险因素分析［J］.中华神经外科杂志,2021, 37(7): 706-710. ［6］毕娜，余清文，任银萍，等.我国上肢创伤骨折患者上肢深静脉血栓发生率的Meta分析［J］.中华现代护理杂志,2019,25(23): 2961-2965. ［7］MENG KK, HU XL, PENG XX, et al. Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis［J］.J Matern Fetal Neonatal Med,2015,28(3): 245-253. ［8］ZHANG C,SHEN L,LE KJ,et al.Incidence of venous thromboembolism in hospitalized coronavirus disease 2019 patients: a systematic review and meta-analysis［J］.Front Cardiovasc Med,2020, 151(7):1-8. ［9］艾飞玲,胡葵茹,石钰霖,等.基于纽卡斯尔-渥太华量表对中国吸烟队列研究文献的质量评价［J］. 中华疾病控制杂志,2021, 25(6): 722-729. ［10］陈慧娇,孙晓红,张喆,等.出血性脑卒中患者下肢深静脉血栓形成风险预测模型的构建与验证［J］.中华神经外科杂志,2021,37（3）:255-259. ［11］余鹏.颅脑创伤患者静脉血栓栓塞的发生率和危险因素分析［D］. 苏州: 苏州大学, 2020. ［12］赵信德，谢韬，连宗德，等. 神经外科患者术前血清炎症因子及血常规预测术后深静脉血栓形成的价值［J］. 实用医学杂志，2018, 34(5): 742-745. ［13］赵银凯，杨波，冯淼淼，等. 术前血常规、凝血指标对神经外科手术患者术后DVT的预测效能［J］. 山东医药，2017, 57(11): 52-54. ［14］付天英. 基于Caprini模型在神经外科术后患者静脉血栓栓塞症危险因素分析［D］. 唐山：华北理工大学, 2019. ［15］杨磊. 神经外科患者术后下肢深静脉血栓形成的临床特点及危险因素分析［D］. 郑州：郑州大学, 2014. ［16］张培花，范金环，陈曦，等. 神经外科术后下肢深静脉血栓形成的危险因素分析［J］. 解放军医药杂志，2018, 30(12): 73-75. ［17］杜伟，郝质言，李方，等. 单纯重度脑创伤患者发生深静脉血栓危险因素分析及其列线图模型构建［J］. 实用心脑肺血管病杂志，2021, 29(6): 28-33. ［18］陈银伟，徐锋. 平均血小板体积与D-二聚体在神经外科患者术后下肢深静脉血栓形成中的预测价值［J］. 中国卫生检验杂志，2019, 29(18): 2244-2247. ［19］李倩，靖倩，尚无怡. 创伤性颅脑损伤患者下肢静脉血栓发生现状及相关因素分析［J］. 中国急救复苏与灾害医学杂志，2020, 15(3): 295-298, 303. ［20］桂喜盈，田无忌，关俊文，等. 脑创伤术后患者高密度脂蛋白胆固醇降低与深静脉血栓的关系［J］. 四川大学学报，2020, 51(1): 118-121. ［21］唐华. 神经外科住院手术患者下肢深静脉血栓形成临床研究［D］. 北京: 首都医科大学, 2006. ［22］贾昊坤. 动脉瘤性蛛网膜下腔出血并发下肢深静脉血栓的相关危险因素分析［D］. 石家庄：河北医科大学, 2018. ［23］袁媛，张冉，李桂云. 颅脑肿瘤患者术后下肢深静脉血栓的危险因素分析［J］. 北京医学，2020, 42(3): 210-213. ［24］徐珑，李凯，陈玉，等. 创伤性颅内出血静脉血栓栓塞症发生的影响因素分析［J］. 中华神经外科杂志，2020, 36(8): 780-784. ［25］孙雪娟，童孜蓉. 创伤性颅内出血病人并发深静脉血栓形成的危险因素［J］. 中国临床神经外科杂志，2019, 24(10): 592-594. ［26］姚天才，赵东升，徐恭达. 颅脑损伤患者深静脉血栓形成的危险因素分析及预防方法［J］. 国际神经病学神经外科学杂志，2011, 38(1): 5-8. ［27］LI Q, YU ZX, CHEN X, et al. Risk factors for deep venous thrombosis of lower limbs in postoperative neurosurgical patients［J］. Pakistan Journal of Medical Sciences，2016, 32(5): 1107-1110. ［28］GEORGE A, NAIR S, KARTHIC J, et al. The incidence of deep venous thrombosis in high-risk Indian neurosurgical patients: need for early chemoprophylaxis［J］. Indian Journal of Critical Care Medicine，2016, 20(7): 412-416. ［29］ROLSTON JD, HAN SJ, BLOCH O, et al. What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients［J］. J Neurosurg，2014, 121(4): 908-918. ［30］LIEBER BA, HAN J, APPELBOOM G, et al.Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis［J］. World Neurosurgery，2016, 89: 126-132. ［31］TRACY BM, DUNNE JR, ONEAL CM, et al.Venous thromboembolism prophylaxis in neurosurgical trauma patients［J］. Journal of Surgical Research，2016, 205(1): 221-227. ［32］MANABU N, TAKEO U, JUN W, et al. High incidence of deep vein thrombosis in the perioperative period of neurosurgical patients［J］. World Neurosurgery，2018,112: 103-112. ［33］CHEANG MY, YEO TT, CHOU N, et al. Is anticoagulation for venous thromboembolism safe for Asian elective neurosurgical patients? A single centre study［J］. ANZ J Surg，2019, 89(7): 919-924. ［34］PATEL AP, KOLTZ MT, SANSUR CA, et al. An analysis of deep vein thrombosis in 1277 consecutive neurosurgical patients undergoing routine weekly ultrasonography［J］. Journal of Neurosurgery，2013, 118(3): 505-509. ［35］SHI SH, CHENG J, ZHAO Y, et al. Incidence, and preoperative and intraoperative prognostic factors of deep venous thrombosis in patients with glioma following craniotomy［J］. Clinical Neurology and Neurosurgery，2021, 210: 106998. ［36］RENNERT RC, MARTIN JR, BRANDEL MG, et al. Risk factors for venous thromboembolism after admission for traumatic subdural hematoma at level I trauma center: large single-institution series［J］. World Neurosurgery，2019, 122(2): 619-626. ［37］GUO XP,ZHANG F, WU Y, et al. Coagulation alternation and deep venous thrombosis in brain tumor patients during the perioperative period［J］. World Neurosurgery，2018，114：e982-e991. ［38］NAKANO F, MATSUBARA T, ISHIGAKI T, et al. Incidence and risk factor of deep venous thrombosis in patients undergoing craniotomy for brain tumors: a Japanese single-center, retrospective study［J］. Thrombosis Research，2018, 165(5): 95-100. ［39］SMITH TR, NANNEY AD, LALL RR, et al. Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10year period［J］. Journal of Clinical Neuroscience，2015, 22(3): 519-525. ［40］KSHETTRY VR, ROSENBAUM BP, SEICEAN A, et al. Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage［J］. Journal of Clinical Neuroscience，2014, 21(2): 282-286. ［41］CARRABBA G, RIVA M, CONTE V, et al. Risk of post-operative venous thromboembolism in patients with meningioma［J］. Journal of Neuro-Oncology，2018, 138(2): 401-406. ［42］DENGLER BA, MENDEZ-GOMEZ P, CHAVEZ A, et al. Safety of chemical DVT prophylaxis in severe traumatic brain injury with invasive monitoring devices［J］. Neurocritical Care，2016, 25(2): 215-223. ［43］LIANG CW, SU K, LIU JJ, et al. Timing of deep vein thrombosis formation after aneurysmal subarachnoid hemorrhage［J］. Journal of Neurosurgery，2016, 123(4): 891-896. ［44］RAY WZ, STROM RG, BLACKBURN SL, et al. Incidence of deep venous thrombosis after subarachnoid hemorrhage［J］. Journal of Neurosurgery，2009, 110(5): 1010. ［45］BORDE TD, PRASAD C, ARIMAPPAMAGAN A, et al. Incidence of deep venous thrombosis in patients undergoing elective neurosurgery - a prospective cohort based study［J］. Neurol India，2017, 65(4): 787-793. ［46］HENWOOD PC, KENNEDY TM, THOMSON L, et al. The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis［J］. Journal of Thrombosis and Thrombolysis，2011, 32(2): 209-214. ［47］SERRONR JC, WASH EM, HARTINGS JA, et al. Venous thromboembolism in subarachnoid hemorrhage［J］. World Neurosurg，2013, 80(6): 859-863. ［48］徐晓峰，杨媛华，翟振国，等. 内科重症监护病房中深静脉血栓的发病情况及危险因素分析［J］. 中华流行病学杂志, 2008,29(10): 1034-1037. ［49］周宇军，林静，石利涛，等. 下肢不同部位骨折DVT发生率的对比研究［J］. 承德医学院学报,2017, 34(2): 104-106. ［50］LI L, ZHOU J, HUANG LQ, et al. Prevention, treatment, and risk factors of deep vein thrombosis in critically ill patients in Zhejiang province, China: a multicenter, prospective, observational study［J］. Annals of Medicine,2021, 53(1): 2236-2247. ［51］乔永丽，闫俊萍，赵彦欣，等. 外科医生对术中深静脉血栓的预防和认知的调查研究［J］. 当代护士, 2021, 28(10): 142-145. ［52］KOEHLER DM, SHIPMAN J, DAVIDSON MA, et al. Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage［J］. J Trauma，2011, 70(2): 324-329. ［53］URBANEK T, LABROPOULOS N. Can we predict and prevent thepostthrombotic syndrome［J］. Vasa，2021, 50(1): 11-21. ［54］周佳，严静，李莉. 重症医学科患者深静脉血栓形成预防现状的研究进展［J］. 中华重症医学电子杂志，2020, 6(3): 314-317. ［55］苗旺，赵珂，郭俊爽，等. 动脉瘤性蛛网膜下腔出血首日凝血功能研究［J］. 中国实用神经疾病杂志，2020, 23(14): 1231-1235. ［56］MIAO W, ZHAO K, DENG WJ, et al. Coagulation factor hyperfunction after subarachnoid hemorrhage induces deep venous thrombosis［J］. World Neurosurg，2018, 110: 46-52. ［57］王洁，童亚慧，邹叶芳，等. 临床护理人员对下肢深静脉血栓的认知现状和预防措施落实情况的调查［J］. 解放军护理杂志，2017, 34(14): 29-32. ［58］国家卫生健康委员会. 关于同意开展加强肺栓塞和医院内静脉血栓栓塞症防治能力建设项目:国卫医资源便函〔2018〕139号［Z］. 2018. ［59］杨颖,郭豫涛,高杨, 等. 解放军总医院静脉血栓栓塞症防治体系构建与思考［J］. 中国卫生质量管理,2022,29(6):28-30. ［60］张文一,李帅,张璇, 等. 住院患者VTE标准化防治管理体系构建与应用［J］. 中国卫生质量管理,2022,29(7):22-25，31.

相似文献/References:

[1]伍琳许苹连斌.神经外科医疗风险预警指标研究[J].中国卫生质量管理,2017,24(05):17.[doi:10.13912/j.cnki.chqm.2017.24.5.07]
[2]程金焱沈慧陈晓虹.提高骨科大手术患者深静脉血栓预防措施落实率[J].中国卫生质量管理,2018,25(03):58.[doi:10.13912/j.cnki.chqm.2018.25.3.19]
[3]李娟姜雪李瑞刚王苗赵天智郭青程莎莎潘卓强媛刘美彤.提高神经外科计划手术完成率[J].中国卫生质量管理,2018,25(03):71.[doi:10.13912/j.cnki.chqm.2018.25.3.22]
[4]郑敏赵艾吴玉燕田英瑞张涛王超王樑屈延.科室层面如何提高床位使用率[J].中国卫生质量管理,2018,25(06):50.[doi:10.13912/j.cnki.chqm.2018.25.6.17]
[5]刘成刚赵志勇孙仁峰.基于三级医院评审标准的静脉血栓栓塞症防控策略研究[J].中国卫生质量管理,2022,29(04):39.[doi:10.13912/j.cnki.chqm.2022.29.4.11 ]
　LIU Chenggang,ZHAO Zhiyong,SUN Renfeng.Prevention and Control Strategies of Venous Thromboembolism Based on Tertiary Hospital Accreditation Standards[J].Chinese Health Quality Management,2022,29(02):39.[doi:10.13912/j.cnki.chqm.2022.29.4.11 ]
[6]高雅刘晓楠李晶易晓平王文爽.颅脑损伤患者深静脉血栓危险因素的Meta分析[J].中国卫生质量管理,2024,31(10):44.[doi:10.13912/j.cnki.chqm.2024.31.10.09]
　GAO Ya,LIU Xiaonan,LI Jing.Meta-Analysis of Risk Factors for Deep Venous Thrombosis in Patients with Traumatic Brain Injury[J].Chinese Health Quality Management,2024,31(02):44.[doi:10.13912/j.cnki.chqm.2024.31.10.09]

更新日期/Last Update: 2023-02-15